PDF Publication Title:
Text from PDF Page: 016
Molecules 2020, 25, 4102 16 of 22 33. George, B.P.; Abrahamse, H. A Review on Novel Breast Cancer Therapies: Photodynamic Therapy and Plant Derived Agent Induced Cell Death Mechanisms. Anti-Cancer Agents Med. Chem. 2016, 15, 1. [CrossRef] 34. Aniogo, E.C.; George, B.P.; Abrahamse, H. The role of photodynamic therapy on multidrug resistant breast cancer. Cancer Cell Int. 2019, 19, 91. [CrossRef] [PubMed] 35. Allison, R.R.; Sibata, C.H. Oncologic photodynamic therapy photosensitizers: A clinical review. Photodiagn. Photodyn. Ther. 2010, 7, 61–75. [CrossRef] [PubMed] 36. Chen, B.; Roskams, T.; De Witte, P.A.M. Antivascular tumor eradication by hypericin-mediated photodynamic therapy. Photochem. Photobiol. 2002, 76, 509. [CrossRef] 37. Ascencio, M.; Collinet, P.; Farine, M.; Mordon, S. Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy. Lasers Surg. Med. 2008, 40, 332–341. [CrossRef] 38. Garg, A.D.; Nowis, D.; Golab, J.; Vandenabeele, P.; Krysko, D.V.; Agostinis, P. Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation. Biochim. Biophys. Acta (BBA) Rev. Cancer 2010, 1805, 53–71. [CrossRef] 39. Castano, A.P.; Demidova, T.N.; Hamblin, M.R. Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagn. Photodyn. Ther. 2005, 2, 91–106. [CrossRef] 40. Ogilby, P.R. Singlet oxygen: There is indeed something new under the sun. Chem. Soc. Rev. 2010, 39, 3181. [CrossRef] 41. Oseroff, A.R.; Blumenson, L.R.; Wilson, B.D.; Mang, T.S.; Bellnier, D.A.; Parsons, J.C.; Frawley, N.; Cooper, M.; Zeitouni, N.; Dougherty, T.J. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin®) for treatment of basal cell carcinoma. Lasers Surg. Med. 2006, 38, 417–426. [CrossRef] 42. Juzeniene, A.; Juzenas, P.; Ma, L.-W.; Iani, V.; Moan, J. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med. Sci. 2004, 19, 139–149. [CrossRef] 43. Lang, P. Methyl aminolaevulinate–photodynamic therapy: A review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Yearb. Dermatol. Dermatol. Surg. 2008, 2008, 322–323. [CrossRef] 44. Jeffes, E.W.; McCullough, J.L.; Weinstein, G.D.; Kaplan, R.; Glazer, S.D.; Taylor, J. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J. Am. Acad. Dermatol. 2001, 45, 96–104. [CrossRef] [PubMed] 45. Lu, K.; He, C.; Lin, W. A Chlorin-Based Nanoscale Metal–Organic Framework for Photodynamic Therapy of Colon Cancers. J. Am. Chem. Soc. 2015, 137, 7600–7603. [CrossRef] [PubMed] 46. Moore, C.M.; Nathan, T.; Lees, W.; Mosse, C.; Freeman, A.; Emberton, M.; Bown, S. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer. Lasers Surg. Med. 2006, 38, 356–363. [CrossRef] 47. Grosjean, P.; Savary, J.-F.; Wagnières, G.; Mizeret, J.; Woodtli, A.; Theumann, J.-F.; Fontolliet, C.; Bergh, H.V.D.; Monnier, P. Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers. Lasers Med. Sci. 1996, 11, 227–235. [CrossRef] 48. Kessel, D. Pharmacokinetics of N-aspartyl chlorin e6 in cancer patients. J. Photochem. Photobiol. B Boil. 1997, 39, 81–83. [CrossRef] 49. Taber, S.W.; Fingar, V.H.; Coots, C.T.; Wieman, T.J. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: A Phase I clinical study. Clin. Cancer Res. 1998, 4, 2741–2746. 50. Lagudaev, D.M. Sorokaty ̆ı Photodynamic therapy of prostatic adenoma. Urologiia 2007, 4, 34–37. 51. Momma, T.; Hamblin, M.R.; Wu, H.C.; Hasan, T. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: Local control and distant metastasis. Cancer Res. 1998, 58, 5425–5431. 52. Levy, J.G.; Waterfield, E.; Richter, A.M.; Smits, C.; Lui, H.; Hruza, L.; Anderson, R.R.; Salvatori, V. Photodynamic therapy of malignancies with benzoporphyrin derivative monoacid ring A. Europto Biomedical Optics ’93 1994, 2078, 91–101. [CrossRef] 53. Young, S.W.; Woodburn, K.W.; Wright, M.; Mody, T.D.; Fan, Q.; Sessler, J.L.; Dow, W.C.; Miller, R.A. Lutetium Texaphyrin (PCI-0123): A Near-Infrared, Water-Soluble Photosensitizer. Photochem. Photobiol. 1996, 63, 892–897. [CrossRef] 54. Sessler, J.L.; Miller, R.A. Texaphyrins: New drugs with diverse clinical applications in radiation and photodynamic therapy. Biochem. Pharmacol. 2000, 59, 733–739. [CrossRef]PDF Image | Role of Photoactive Phytocompounds in Photodynamic Therapy of Cancer
PDF Search Title:
Role of Photoactive Phytocompounds in Photodynamic Therapy of CancerOriginal File Name Searched:
molecules-25-04102.pdfDIY PDF Search: Google It | Yahoo | Bing
Cruise Ship Reviews | Luxury Resort | Jet | Yacht | and Travel Tech More Info
Cruising Review Topics and Articles More Info
Software based on Filemaker for the travel industry More Info
The Burgenstock Resort: Reviews on CruisingReview website... More Info
Resort Reviews: World Class resorts... More Info
The Riffelalp Resort: Reviews on CruisingReview website... More Info
CONTACT TEL: 608-238-6001 Email: greg@cruisingreview.com (Standard Web Page)